AI Engines For more Details: Perplexity Kagi Labs You
Hypertension (High Blood Pressure): Quinethazone is commonly prescribed to manage hypertension. As a diuretic, it works by increasing the excretion of sodium and water by the kidneys, leading to a decrease in blood volume and ultimately lowering blood pressure. By reducing the volume of fluid circulating in the blood vessels, it helps to decrease the workload on the heart and improve blood pressure control.
Edema: Quinethazone is also used to treat edema, which is the abnormal accumulation of fluid in the body's tissues, often manifested as swelling in the legs, feet, ankles, or abdomen. By promoting diuresis, quinethazone helps to remove excess fluid from the body, reducing swelling and relieving symptoms associated with edema.
Congestive Heart Failure: In cases of congestive heart failure, quinethazone may be prescribed as part of a treatment regimen to help reduce fluid retention and alleviate symptoms such as shortness of breath, fatigue, and swelling. By reducing fluid overload, it can help improve cardiac function and overall well-being in individuals with heart failure.
Nephrolithiasis (Kidney Stones): Thiazide diuretics like quinethazone can be used to prevent the formation of certain types of kidney stones by increasing the excretion of calcium in the urine. By reducing urinary calcium concentration, they can help to decrease the risk of stone formation in susceptible individuals.
Diabetes Insipidus: Quinethazone may be used in the management of diabetes insipidus, a condition characterized by excessive urination and thirst due to impaired regulation of fluid balance by the kidneys. By promoting diuresis and reducing urine output, it can help to alleviate symptoms and maintain fluid balance in patients with diabetes insipidus.
Off-label Uses: Quinethazone may also be prescribed off-label for other conditions, such as premenstrual syndrome (PMS), polycystic ovary syndrome (PCOS), and idiopathic hypercalciuria (excessive urinary calcium excretion). However, the evidence supporting its use for these indications may be limited, and its efficacy and safety should be carefully evaluated by a healthcare professional.
Rank | Probiotic | Impact |
---|---|---|
species | Anaerobutyricum hallii | Reduces |
species | Christensenella minuta | Reduces |
species | Escherichia coli | Reduces |
species | Lacticaseibacillus paracasei | Reduces |
species | Lactococcus cremoris | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Lacticaseibacillus | genus | Decreases |
0 | 1 | Coprococcus | genus | Decreases |
0 | 1 | Bilophila | genus | Decreases |
0 | 1 | Subdoligranulum | genus | Decreases |
0 | 1 | Wansuia | genus | Decreases |
0 | 1 | Anaerobutyricum | genus | Decreases |
0 | 1 | Komagataeibacter | genus | Decreases |
0 | 1 | Christensenella | genus | Decreases |
0 | 1 | Lacrimispora | genus | Decreases |
0 | 1 | Butyrivibrio | genus | Decreases |
0 | 1 | Maliibacterium | genus | Decreases |
0 | 1 | Catenibacterium | genus | Decreases |
0 | 1 | Faecalitalea | genus | Decreases |
0 | 1 | Novisyntrophococcus | genus | Decreases |
0 | 1 | Treponema | genus | Decreases |
0 | 1 | Massilistercora | genus | Decreases |
0 | 1 | Eubacterium | genus | Decreases |
0 | 1 | Wujia | genus | Decreases |
0 | 1 | Ligilactobacillus | genus | Decreases |
0 | 1 | Ruminococcus | genus | Decreases |
0 | 1 | Qiania | genus | Decreases |
0 | 1 | Lachnoanaerobaculum | genus | Decreases |
0 | 1 | Phocaeicola | genus | Decreases |
0 | 1 | Chordicoccus | genus | Decreases |
0 | 1 | Escherichia | genus | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Agathobacter | genus | Decreases |
0 | 1 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 1 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 1 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 1 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 1 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 1 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 1 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 1 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 1 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 1 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 1 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 1 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 1 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 1 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | Escherichia coli O103 | serogroup | Decreases |
0 | 1 | Escherichia coli O111 | serogroup | Decreases |
0 | 1 | Escherichia coli O119 | serogroup | Decreases |
0 | 1 | Escherichia coli O121 | serogroup | Decreases |
0 | 1 | Escherichia coli O145 | serogroup | Decreases |
0 | 1 | Escherichia coli O155 | serogroup | Decreases |
0 | 1 | Escherichia coli O157 | serogroup | Decreases |
0 | 1 | Escherichia coli O177 | serogroup | Decreases |
0 | 1 | Escherichia coli O26 | serogroup | Decreases |
0 | 1 | Escherichia coli O3 | serogroup | Decreases |
0 | 1 | Escherichia coli O43 | serogroup | Decreases |
0 | 1 | Escherichia coli O5 | serogroup | Decreases |
0 | 1 | Escherichia coli O78 | serogroup | Decreases |
0 | 1 | Escherichia coli O86 | serogroup | Decreases |
0 | 1 | Escherichia coli O91 | serogroup | Decreases |
0 | 1 | Escherichia coli H20 | serotype | Decreases |
0 | 1 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 1 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 1 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 1 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 1 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H- | serotype | Decreases |
0 | 1 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O111:NM | serotype | Decreases |
0 | 1 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 1 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 1 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 1 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 1 | Escherichia coli O145:NM | serotype | Decreases |
0 | 1 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 1 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H- | serotype | Decreases |
0 | 1 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 1 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O157:NM | serotype | Decreases |
0 | 1 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 1 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 1 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 1 | Escherichia coli O177:NM | serotype | Decreases |
0 | 1 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 1 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O25:NM | serotype | Decreases |
0 | 1 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 1 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 1 | Escherichia coli O39:NM | serotype | Decreases |
0 | 1 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 1 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 1 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 1 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 1 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 1 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 1 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 1 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 1 | Escherichia coli O81:NM | serotype | Decreases |
0 | 1 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 1 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 1 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 1 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 1 | Escherichia coli O91:NM | serotype | Decreases |
0 | 1 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 1 | Escherichia coli ONT:H33 | serotype | Decreases |
1 | 0 | Lacticaseibacillus paracasei | species | Decreases |
1 | 0 | Coprococcus comes | species | Decreases |
1 | 0 | Bilophila wadsworthia | species | Decreases |
1 | 0 | Phocaeicola vulgatus | species | Decreases |
0 | 1 | Dorea longicatena | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
0 | 1 | Blautia obeum | species | Decreases |
0 | 1 | Dorea formicigenerans | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
0 | 1 | Anaerobutyricum hallii | species | Decreases |
0 | 1 | Blautia sp. SC05B48 | species | Decreases |
0 | 1 | Ligilactobacillus ruminis | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
0 | 1 | Fannyhessea vaginae | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
0 | 1 | Lacrimispora saccharolytica | species | Decreases |
0 | 1 | [Ruminococcus] lactaris | species | Decreases |
0 | 1 | Eubacterium ventriosum | species | Decreases |
0 | 1 | Coprococcus eutactus | species | Decreases |
0 | 1 | Clostridium sp. M62/1 | species | Decreases |
0 | 1 | Lachnoanaerobaculum gingivalis | species | Decreases |
0 | 1 | Blautia liquoris | species | Decreases |
0 | 1 | Christensenella minuta | species | Decreases |
0 | 1 | Clostridium sp. SY8519 | species | Decreases |
0 | 1 | Butyrivibrio crossotus | species | Decreases |
0 | 1 | Coprococcus sp. ART55/1 | species | Decreases |
0 | 1 | Faecalibacterium duncaniae | species | Decreases |
0 | 1 | Catenibacterium mitsuokai | species | Decreases |
0 | 1 | Faecalitalea cylindroides | species | Decreases |
0 | 1 | Massilistercora timonensis | species | Decreases |
0 | 1 | Eubacterium sp. MSJ-33 | species | Decreases |
0 | 1 | Maliibacterium massiliense | species | Decreases |
0 | 1 | Novisyntrophococcus fermenticellae | species | Decreases |
0 | 1 | Treponema peruense | species | Decreases |
0 | 1 | Eubacterium limosum | species | Decreases |
0 | 1 | Catenibacterium sp. co_0103 | species | Decreases |
0 | 1 | Qiania dongpingensis | species | Decreases |
0 | 1 | Faecalibacillus intestinalis | species | Decreases |
0 | 1 | Ruminococcus albus | species | Decreases |
0 | 1 | Eubacterium maltosivorans | species | Decreases |
0 | 1 | Butyrivibrio fibrisolvens | species | Decreases |
0 | 1 | Roseburia hominis | species | Decreases |
0 | 1 | Eubacterium callanderi | species | Decreases |
0 | 1 | Faecalibacterium sp. I2-3-92 | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-1-79 | species | Decreases |
0 | 1 | [Clostridium] hylemonae | species | Decreases |
0 | 1 | Olsenella sp. oral taxon 807 | species | Decreases |
0 | 1 | Ruminococcus champanellensis | species | Decreases |
0 | 1 | Faecalibacterium sp. HTF-F | species | Decreases |
0 | 1 | Intestinibaculum porci | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-3-29 | species | Decreases |
0 | 1 | Anaerostipes hadrus | species | Decreases |
0 | 1 | Pseudobutyrivibrio xylanivorans | species | Decreases |
0 | 1 | Clostridium cadaveris | species | Decreases |
0 | 1 | Phoenicibacter congonensis | species | Decreases |
0 | 1 | Actinomyces naeslundii | species | Decreases |
1 | 0 | Escherichia coli | species | Decreases |
0 | 1 | Lactococcus cremoris | species | Decreases |
1 | 0 | [Ruminococcus] torques | species | Decreases |
1 | 0 | Agathobacter rectalis | species | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. paracasei | subspecies | Decreases |
0 | 1 | Lacticaseibacillus paracasei subsp. tolerans | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.3 | 0.3 | |
ADHD | 0.1 | 0.7 | -6 |
Age-Related Macular Degeneration and Glaucoma | 0.1 | 0.1 | |
Allergic Rhinitis (Hay Fever) | 0.2 | 0.2 | 0 |
Allergies | 0.9 | 0.3 | 2 |
Allergy to milk products | 0.8 | 0.2 | 3 |
Alopecia (Hair Loss) | 0.1 | 0.1 | |
Alzheimer's disease | 0.9 | 1.1 | -0.22 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 0.5 | 0.4 | 0.25 |
Ankylosing spondylitis | 0.2 | 0.2 | 0 |
Anorexia Nervosa | 0.1 | 0.2 | -1 |
Antiphospholipid syndrome (APS) | 0.1 | 0.2 | -1 |
Asthma | 0.1 | 0.1 | 0 |
Atherosclerosis | 0.2 | 0.1 | 1 |
Atrial fibrillation | 0.4 | 0.4 | 0 |
Autism | 0.9 | 1.2 | -0.33 |
Autoimmune Disease | 0.1 | 0.1 | |
benign prostatic hyperplasia | 0.1 | 0.1 | |
Biofilm | 0.1 | 0.1 | |
Bipolar Disorder | 0.3 | 0.4 | -0.33 |
Brain Trauma | 0.2 | -0.2 | |
Breast Cancer | 0.1 | 0.1 | |
Cancer (General) | 0.6 | -0.6 | |
Carcinoma | 0.8 | 0.6 | 0.33 |
Celiac Disease | 0.4 | 0.4 | 0 |
Cerebral Palsy | 0.1 | -0.1 | |
Chronic Fatigue Syndrome | 0.7 | 2.4 | -2.43 |
Chronic Kidney Disease | 0.5 | 1 | -1 |
Chronic Obstructive Pulmonary Disease (COPD) | 0.4 | 0.4 | 0 |
Chronic Urticaria (Hives) | 0.2 | 0.2 | |
Coagulation / Micro clot triggering bacteria | 0.3 | 0.5 | -0.67 |
Cognitive Function | 0.2 | 0.2 | 0 |
Colorectal Cancer | 1 | 0.4 | 1.5 |
Constipation | 0.4 | 0.4 | |
Coronary artery disease | 0.7 | 0.7 | 0 |
COVID-19 | 1 | 2 | -1 |
Crohn's Disease | 1.4 | 1.2 | 0.17 |
Cushing's Syndrome (hypercortisolism) | 0.2 | -0.2 | |
cystic fibrosis | 0.2 | 0.2 | |
d-lactic acidosis (one form of brain fog) | 0.1 | 0.1 | |
deep vein thrombosis | 0.5 | 0.5 | 0 |
Depression | 1.9 | 2.2 | -0.16 |
Eczema | 0.1 | 0.1 | 0 |
Endometriosis | 0.5 | 0.5 | 0 |
Epilepsy | 0.4 | 0.2 | 1 |
erectile dysfunction | 0.1 | 0.1 | |
Fibromyalgia | 0.7 | -0.7 | |
Functional constipation / chronic idiopathic constipation | 1 | 0.8 | 0.25 |
gallstone disease (gsd) | 0.3 | 0.1 | 2 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.2 | 0.5 | -1.5 |
Generalized anxiety disorder | 0.4 | 0.4 | 0 |
Glioblastoma | 0.1 | 0.1 | |
Gout | 0.1 | 0.3 | -2 |
Graves' disease | 0.1 | 0.1 | 0 |
Gulf War Syndrome | 0.3 | 0.3 | |
Halitosis | 0.2 | 0.2 | |
Hashimoto's thyroiditis | 0.5 | 0.4 | 0.25 |
Heart Failure | 0.9 | 0.4 | 1.25 |
hemorrhagic stroke | 0.1 | 0.1 | |
Hidradenitis Suppurativa | 0.2 | 0.2 | |
High Histamine/low DAO | 0.1 | 0.1 | 0 |
hypercholesterolemia (High Cholesterol) | 0.1 | 0.1 | |
hyperglycemia | 0.2 | 0.2 | |
Hyperlipidemia (High Blood Fats) | 0.3 | 0.3 | |
hypersomnia | 0.2 | -0.2 | |
hypertension (High Blood Pressure | 0.6 | 1 | -0.67 |
Hypothyroidism | 0.1 | 0.6 | -5 |
IgA nephropathy (IgAN) | 0.2 | 0.3 | -0.5 |
Inflammatory Bowel Disease | 1.1 | 1.5 | -0.36 |
Insomnia | 0.6 | 0.1 | 5 |
Intelligence | 0.4 | 0.3 | 0.33 |
Intracranial aneurysms | 0.1 | 0.4 | -3 |
Irritable Bowel Syndrome | 0.7 | 1 | -0.43 |
ischemic stroke | 0.2 | 0.1 | 1 |
Juvenile idiopathic arthritis | 0.1 | -0.1 | |
Liver Cirrhosis | 1.2 | 1 | 0.2 |
Long COVID | 1.6 | 1.6 | 0 |
Low bone mineral density | 0.6 | -0.6 | |
Lung Cancer | 0.2 | 0.3 | -0.5 |
Lymphoma | 0.1 | 0.1 | |
Mast Cell Issues / mastitis | 0.1 | 0.4 | -3 |
ME/CFS with IBS | 1.5 | -1.5 | |
ME/CFS without IBS | 0.2 | 0.4 | -1 |
Menopause | 0.1 | 0.1 | 0 |
Metabolic Syndrome | 1.9 | 1.6 | 0.19 |
Mood Disorders | 1.8 | 1.7 | 0.06 |
Multiple Sclerosis | 0.5 | 0.7 | -0.4 |
Multiple system atrophy (MSA) | 0.1 | 0.1 | 0 |
myasthenia gravis | 0.1 | 0.1 | 0 |
neuropathic pain | 0.1 | -0.1 | |
Neuropathy (all types) | 0.1 | 0.1 | 0 |
neuropsychiatric disorders (PANDAS, PANS) | 0.1 | 0.1 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 0.5 | 1.1 | -1.2 |
Obesity | 1.8 | 1.8 | 0 |
obsessive-compulsive disorder | 0.9 | 0.5 | 0.8 |
Osteoarthritis | 0.4 | 0.4 | 0 |
Osteoporosis | 0.2 | 0.2 | 0 |
Parkinson's Disease | 1.5 | 1.1 | 0.36 |
Polycystic ovary syndrome | 0.9 | 0.3 | 2 |
Postural orthostatic tachycardia syndrome | 0.3 | -0.3 | |
primary biliary cholangitis | 0.1 | 0.1 | |
Primary sclerosing cholangitis | 0.9 | -0.9 | |
Psoriasis | 0.4 | 0.3 | 0.33 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 1.2 | 0.4 | 2 |
Rosacea | 0.2 | 0.2 | |
Schizophrenia | 0.8 | 0.5 | 0.6 |
scoliosis | 0.6 | 0.3 | 1 |
sensorineural hearing loss | 0.2 | 0.2 | |
Sjögren syndrome | 0.1 | 0.2 | -1 |
Sleep Apnea | 0.5 | 0.3 | 0.67 |
Slow gastric motility / Gastroparesis | 0.3 | 0.3 | |
Small Intestinal Bacterial Overgrowth (SIBO) | 0.5 | 0.5 | |
Stress / posttraumatic stress disorder | 0.2 | 0.3 | -0.5 |
Systemic Lupus Erythematosus | 0.6 | 0.3 | 1 |
Tic Disorder | 0.3 | 0.4 | -0.33 |
Type 1 Diabetes | 0.8 | 0.6 | 0.33 |
Type 2 Diabetes | 1.9 | 1.6 | 0.19 |
Ulcerative colitis | 1 | 1.2 | -0.2 |
Unhealthy Ageing | 0.7 | 0.6 | 0.17 |
Vitiligo | 0.2 | 0.6 | -2 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]